By downregulating the biosynthesis of Bcl2 and Bcl-xL through the p53 signaling pathway, a notable apoptotic target in many cancer types, flavonoids diminish a significant dysregulated pathway in cancer [54]. This evidence concerns the gene BCL2L1 and cancer.